LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Erlotinib | 0.12 | uM | LJP5 | 2 | M23 | 72 | hr | 1476 | 3273 | 3694 | 0.8860 | 0.8101 |
| SK-BR-3 | Erlotinib | 0.12 | uM | LJP5 | 3 | M23 | 72 | hr | 1476 | 3240 | 3694 | 0.8771 | 0.7952 |
| SK-BR-3 | Foretinib | 0.12 | uM | LJP5 | 1 | H11 | 72 | hr | 1476 | 2698 | 3694 | 0.7304 | 0.5508 |
| SK-BR-3 | Foretinib | 0.12 | uM | LJP5 | 2 | H11 | 72 | hr | 1476 | 2561 | 3694 | 0.6933 | 0.4890 |
| SK-BR-3 | Foretinib | 0.12 | uM | LJP5 | 3 | H11 | 72 | hr | 1476 | 2624 | 3694 | 0.7103 | 0.5174 |
| SK-BR-3 | R406 | 0.12 | uM | LJP6 | 1 | C17 | 72 | hr | 1476 | 3581 | 3694 | 0.9694 | 0.9490 |
| SK-BR-3 | R406 | 0.12 | uM | LJP6 | 2 | C17 | 72 | hr | 1476 | 3696 | 3694 | 1.0005 | 1.0009 |
| SK-BR-3 | R406 | 0.12 | uM | LJP6 | 3 | C17 | 72 | hr | 1476 | 3807 | 3694 | 1.0306 | 1.0509 |
| SK-BR-3 | Pictilisib | 0.12 | uM | LJP6 | 1 | D23 | 72 | hr | 1476 | 1841 | 3694 | 0.4984 | 0.1643 |
| SK-BR-3 | Pictilisib | 0.12 | uM | LJP6 | 2 | D23 | 72 | hr | 1476 | 2211 | 3694 | 0.5985 | 0.3312 |
| SK-BR-3 | Pictilisib | 0.12 | uM | LJP6 | 3 | D23 | 72 | hr | 1476 | 2266 | 3694 | 0.6134 | 0.3560 |
| SK-BR-3 | Gefitinib | 0.12 | uM | LJP6 | 1 | N11 | 72 | hr | 1476 | 2636 | 3694 | 0.7136 | 0.5228 |
| SK-BR-3 | Gefitinib | 0.12 | uM | LJP6 | 2 | N11 | 72 | hr | 1476 | 3178 | 3694 | 0.8603 | 0.7673 |
| SK-BR-3 | Gefitinib | 0.12 | uM | LJP6 | 3 | N11 | 72 | hr | 1476 | 3154 | 3694 | 0.8538 | 0.7564 |
| SK-BR-3 | Geldanamycin | 0.12 | uM | LJP5 | 1 | O05 | 72 | hr | 1476 | 1309 | 3694 | 0.3544 | -0.0756 |
| SK-BR-3 | Geldanamycin | 0.12 | uM | LJP5 | 2 | O05 | 72 | hr | 1476 | 1365 | 3694 | 0.3695 | -0.0504 |
| SK-BR-3 | Geldanamycin | 0.12 | uM | LJP5 | 3 | O05 | 72 | hr | 1476 | 1493 | 3694 | 0.4042 | 0.0073 |
| SK-BR-3 | Geldanamycin | 0.12 | uM | LJP6 | 1 | O05 | 72 | hr | 1476 | 1361 | 3694 | 0.3684 | -0.0522 |
| SK-BR-3 | Geldanamycin | 0.12 | uM | LJP6 | 2 | O05 | 72 | hr | 1476 | 1405 | 3694 | 0.3803 | -0.0323 |
| SK-BR-3 | Geldanamycin | 0.12 | uM | LJP6 | 3 | O05 | 72 | hr | 1476 | 1216 | 3694 | 0.3292 | -0.1176 |
| SK-BR-3 | GSK1059615 | 0.12 | uM | LJP5 | 1 | E05 | 72 | hr | 1476 | 3667 | 3694 | 0.9927 | 0.9878 |
| SK-BR-3 | GSK1059615 | 0.12 | uM | LJP5 | 2 | E05 | 72 | hr | 1476 | 3801 | 3694 | 1.0290 | 1.0482 |
| SK-BR-3 | GSK1059615 | 0.12 | uM | LJP5 | 3 | E05 | 72 | hr | 1476 | 3557 | 3694 | 0.9629 | 0.9382 |
| SK-BR-3 | GSK1059615 | 0.12 | uM | LJP6 | 1 | C05 | 72 | hr | 1476 | 2915 | 3694 | 0.7891 | 0.6487 |
| SK-BR-3 | GSK1059615 | 0.12 | uM | LJP6 | 2 | C05 | 72 | hr | 1476 | 3141 | 3694 | 0.8503 | 0.7506 |